CYP1B1 and pulmonary arterial hypertension: Polymorphisms in CYP1B1 that cause preferential metabolism of oestrogen to 16αOHE1 result in the development of PAH in females, whereas females who preferentially metabolise oestrogen into 2OHE1 or 4OHE1 do not [29, 30].